WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016061145) SYNTHETIC PROTEOGLYCANS FOR PREVENTING TISSUE ADHESION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/061145    International Application No.:    PCT/US2015/055396
Publication Date: 21.04.2016 International Filing Date: 13.10.2015
IPC:
A61K 38/10 (2006.01), A61K 47/48 (2006.01), A61K 31/726 (2006.01), A61K 31/727 (2006.01), A61K 31/728 (2006.01)
Applicants: SYMIC IP, LLC [US/US]; 953 Indiana Street San Francisco, California 94107 (US)
Inventors: BACHTELL, Nathan; (US)
Agent: TANNER, Lorna L.; Sheppard Mullin Richter & Hampton LLP 379 Lytton Avenue Palo Alto, California 94301-1479 (US)
Priority Data:
62/063,336 13.10.2014 US
Title (EN) SYNTHETIC PROTEOGLYCANS FOR PREVENTING TISSUE ADHESION
(FR) PROTÉOGLYCANES SYNTHÉTIQUES POUR EMPÊCHER L'ADHÉRENCE TISSULAIRE
Abstract: front page image
(EN)This disclosure provides compositions and methods for treating and/or preventing tissue adhesion, such as abdominal or pelvic adhesion, tendon adhesion or cardiac tissue adhesion in a patient in need thereof by applying a pharmaceutical composition on an unnaturally exposed tissue of an abdominal organ, tendon or cardiac tissue respectively, wherein the composition contains a synthetic proteoglycan capable of binding to collagen.
(FR)La présente invention concerne des compositions et des procédés pour le traitement et/ou la prévention de l'adhérence tissulaire, de telle sorte que l'adhérence abdominale ou pelvienne, l'adhérence des tendons ou l'adhérence du tissu cardiaque chez un patient en ayant besoin par application d'une composition pharmaceutique sur un tissu anormalement exposé d'un organe abdominal, d'un tendon ou de tissu cardiaque respectivement, la composition contenant un protéoglycane synthétique capable de se lier au collagène.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)